+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Drug Delivery Devices Global Market Report 2021: COVID-19 Implications and Growth to 2030

  • ID: 5317318
  • Report
  • April 2021
  • Region: Global
  • The Business Research Company

FEATURED COMPANIES

  • 3M Company
  • B. Braun Melsungen AG
  • Boehringer Ingelheim
  • Enable Injections
  • Insulet Corporation
  • Novartis AG
Drug Delivery Devices Global Market Report 2021: COVID-19 Implications and Growth to 2030 covers this critical market and the impact on it from the COVID-19 virus. It provides strategists, marketers and senior management with the critical information they need to assess the increasing demand for drug delivery devices which play a critical role in the treatment of patients with COVID-19.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 20+ geographies.
  • Understand how the market is experiencing rapid growth due to the coronavirus and how it is likely to stabilize as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:

Where is the largest and fastest growing market for the drug delivery devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Drug Delivery Devices market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider drug delivery devices market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The drug delivery devices market section of the report gives context. It compares the drug delivery devices market with other segments of the drug delivery devices market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, drug delivery devices indicators comparison.
Scope

Markets Covered:

1) By Route Of Administration: Oral Drug Delivery; Injectable Drug Delivery; Topical Drug Delivery; Ocular Drug Delivery; Pulmonary Drug Delivery; Nasal Drug Delivery; Transmucosal Drug Delivery; Implantable Drug Delivery
2) By Patient Care Setting: Hospitals; Diagnostic Centers; Ambulatory Surgery Centers/Clinics; Home Care Settings; Others
3) By Application: Cancer; Infectious Diseases; Respiratory Diseases; Diabetes; Cardiovascular Diseases; Autoimmune Diseases; Central Nervous System Disorders; Others

Companies Mentioned: F. Hoffmann-La Roche Ltd; 3M Company; Pfizer Inc.; Baxter International

Countries: Brazil; China; France; Germany; India; Indonesia; Japan; South Korea; Russia; UK; USA; Australia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, per capita expenditure.

Data Segmentations: Country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

This report will be delivered within 1-3 business days.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 3M Company
  • B. Braun Melsungen AG
  • Boehringer Ingelheim
  • Enable Injections
  • Insulet Corporation
  • Novartis AG
1. Executive Summary

2. Drug Delivery Devices Market Characteristics

3. Drug Delivery Devices Market Trends And Strategies

4. Impact Of COVID-19 On Drug Delivery Devices

5. Drug Delivery Devices Market Size And Growth
5.1. Global Drug Delivery Devices Historic Market, 2015-2020, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Drug Delivery Devices Forecast Market, 2020-2025F, 2030F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market

6. Drug Delivery Devices Market Segmentation
6.1. Global Drug Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Oral Drug Delivery
  • Injectable Drug Delivery
  • Topical Drug Delivery
  • Ocular Drug Delivery
  • Pulmonary Drug Delivery
  • Nasal Drug Delivery
  • Transmucosal Drug Delivery
  • Implantable Drug Delivery
6.2. Global Drug Delivery Devices Market, Segmentation By Patient Care Setting, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospitals
  • Diagnostic Centers
  • Ambulatory Surgery Centers/Clinics
  • Home Care Settings
  • Others
6.3. Global Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Cancer
  • Infectious Diseases
  • Respiratory Diseases
  • Diabetes
  • Cardiovascular Diseases
  • Autoimmune Diseases
  • Central Nervous System Disorders
  • Others
7. Drug Delivery Devices Market Regional And Country Analysis
7.1. Global Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
7.2. Global Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Drug Delivery Devices Market
8.1. Asia-Pacific Drug Delivery Devices Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Drug Delivery Devices Market
9.1. China Drug Delivery Devices Market Overview
9.2. China Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Drug Delivery Devices Market
10.1. India Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Drug Delivery Devices Market
11.1. Japan Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Drug Delivery Devices Market
12.1. Australia Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Drug Delivery Devices Market
13.1. Indonesia Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Drug Delivery Devices Market
14.1. South Korea Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Drug Delivery Devices Market
15.1. Western Europe Drug Delivery Devices Market Overview
15.2. Western Europe Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Drug Delivery Devices Market
16.1. UK Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Drug Delivery Devices Market
17.1. Germany Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Drug Delivery Devices Market
18.1. France Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Drug Delivery Devices Market
19.1. Eastern Europe Drug Delivery Devices Market Overview
19.2. Eastern Europe Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Drug Delivery Devices Market
20.1. Russia Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Drug Delivery Devices Market
21.1. North America Drug Delivery Devices Market Overview
21.2. North America Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Drug Delivery Devices Market
22.1. USA Drug Delivery Devices Market Overview
22.2. USA Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Drug Delivery Devices Market
23.1. South America Drug Delivery Devices Market Overview
23.2. South America Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Drug Delivery Devices Market
24.1. Brazil Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Drug Delivery Devices Market
25.1. Middle East Drug Delivery Devices Market Overview
25.2. Middle East Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Drug Delivery Devices Market
26.1. Africa Drug Delivery Devices Market Overview
26.2. Africa Drug Delivery Devices Market, Segmentation By Type (Route of Administration ), Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Drug Delivery Devices Market Competitive Landscape And Company Profiles
27.1. Drug Delivery Devices Market Competitive Landscape
27.2. Drug Delivery Devices Market Company Profiles
27.2.1. BD/Becton, Dickinson
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Novartis AG
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Pfizer Inc
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Johnson & Johnson Services, Inc
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Gerresheimer AG
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Drug Delivery Devices Market

29. Drug Delivery Devices Market Future Outlook and Potential Analysis

30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Research Inquiries
30.4. About the Publisher
30.5. Copyright And Disclaimer
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 3M Company
  • B. Braun Melsungen AG
  • Boehringer Ingelheim
  • Enable Injections
  • Insulet Corporation
  • Novartis AG
Major players in the drug delivery devices market are F. Hoffmann-La Roche Ltd, 3M Company, Pfizer Inc., Baxter International, BD., Novartis AG, Gerresheimer AG, Johnson & Johnson Services, Inc., Bayer AG, and GlaxoSmithKline plc.

The global drug delivery devices market is expected to grow from $40.7 billion in 2020 to $42.76 billion in 2021 at a compound annual growth rate (CAGR) of 5.1%. The change in growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The market is expected to reach $50.9 billion in 2025 at a CAGR of 4.5%.

The drug delivery devices market consists of the sales of medical devices and equipment that are used for delivering specific drugs to a specific part of the body to cure chronic diseases such as cancer, infectious diseases, respiratory diseases, diabetes, cardiovascular diseases. The market includes the sales of the devices that are specifically made for delivering the specific drugs according to the various administration techniques such as oral drug delivery, injectable drug delivery, topical drug delivery, ocular drug delivery, pulmonary drug delivery, nasal drug delivery, transmucosal drug delivery and implantable drug delivery. Drug delivery devices used in various patient care settings such as hospitals, diagnostic centres, pharmaceutical companies, clinics and home care settings are included in this market.

owing to the Covid-19 pandemic. Drugs used for Covid-19 treatment are both oral and injectable; however, a marginal increase is expected for pulmonary or respiratory-based drug delivery devices.

The regulatory changes related to medical devices is expected to restraint the growth of drug delivery devices market. The companies operating in the market are required to adapt according to the changes in the regulatory framework, which may limit business at the bottom line. Also, companies will have to bear the heavy cost of adapting to the changing regulatory framework. Also, the sudden changes in the regulatory framework related to medical devices can result in losses, fines, penalties at a global level. For instance, European Union (EU) and the parliament in 2017 approved the new Medical Device Regulation (MDR) and Medical Device Single Audit Program (MDSAP) to monitor all the medical devices for quality. The new MDSAP will come into effect from 2020 and is adopted by regulators in the US, Canada, Japan, Brazil, and Australia. Following the changes, in Canada, all the medical device manufacturers including drug delivery products manufacturers, will have to comply with the requirements of MDSAP and are required to submit the MDSAP reports to the regulatory body in order to obtain or maintain the device licenses, resulting in high costs and time loss. Thus, the growth of the drug delivery devices market is limited by the regulatory changes related to medical devices.

The microneedle (MN), is a highly efficient and versatile medical device technology, due to its prominent properties including painless penetration, low cost, excellent therapeutic efficacy, and relative safety. The major players operating in the global microneedle drug delivery system include, 3M, Vetter Pharma International GmbH, nano Biosciences LLC, Nano Pass and more. The microneedles are fabricated using biodegradable polymers in which drugs or vaccines are encapsulated in the microneedles. Once, the microneedles dissolve in the skin, the drug gets released. This novel delivery method allows a wider variety of molecules to pass the skin’s barrier, thus allowing the transdermal delivery to be applied to a large range of clinical applications, including diabetes, severe osteoporosis, and influenza vaccination.

Companies in the drug delivery devices market are collaborating with other companies within the industry in order to strengthen their product portfolio as well as to expand their footprint across different geographies. For example, in December 2019, Leo Pharma, a Danish pharmaceutical company, has collaborated with Portal Instruments to build Portal's advanced needle-free drug delivery system for use in conjunction with LEO Pharma's research and approved drug portfolio. This simplifies administration and removes the need for sharp containers at home, and also decreases the time required for self-injections.

In August 2020, Sulzer, a Swiss-based engineering and manufacturing firm acquired Haselmeier GmbH for $118m. The acquisition of Haselmeier will allow Sulzer to complement its healthcare portfolio, in addition to leveraging its APS expertise in precision injection moulding to expand its presence in the drug delivery devices market. Haselmeier GmbH, a Swiss-German drug delivery device developer and manufacturer.

The rising prevalence of chronic diseases such as cardiovascular diseases, diabetes, cancer and other diseases is expected to drive the drug delivery devices market. According to the world health organization (WHO), by 2020, chronic diseases will account for almost three-quarters of all deaths worldwide, and that 71% of deaths due to ischemic heart disease (IHD), 75% of deaths due to stroke, and 70% of deaths due to diabetes will occur in developing countries. There are various routes of drug administration for medical drugs. The selection of the route depends on three factors - the effect desired; the type of the disease and the type of the product. Currently, the development of new drug delivery systems plays a major role in pharmaceutical industries. Research and development (R&D) in drug delivery are increasing throughout the world due to increasing prevalence of these diseases. Most of the pharmaceutical companies are focusing on multiple drug delivery technologies for creating excellent advantages and better outcome for their marketed products. Hence, the increasing prevalence of chronic diseases is resulting in increased consumption of therapeutic drugs and therapies, and this factor is expected to act as a driver for the growth of the drug delivery devices market.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • F. Hoffmann-La Roche Ltd
  • 3M Company
  • Pfizer Inc.
  • Baxter International
  • BD
  • Novartis AG
  • Gerresheimer AG
  • Johnson & Johnson Services, Inc.
  • Bayer AG
  • GlaxoSmithKline plc
  • B. Braun Melsungen AG
  • Cipla Inc.
  • Boehringer Ingelheim
  • Antares Pharma
  • Sulzer Ltd
  • Sanofi
  • Novosanis
  • MEDMIX SYSTEMS AG
  • Merck & Co., Inc.
  • Insulet Corporation
  • OraSure Technologies, Inc.
  • Enable Injections
  • West Pharmaceutical Services, Inc.
  • SMC Ltd.
  • ViVO Smart Medical Devices Ltd.
  • Smith Medical
  • CareFusion Corporation
  • Abbott Laboratories
  • Nipro Corporation
  • Allergan
  • Catalent
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll